Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Prisca Baah Nketia, Edward Ntim Gasu, Jehoshaphat Oppong Mensah & Lawrence Sheringham Borquaye. (2023) In silico identification of α-bisabolol and letestuianin C as potential inhibitors of Trypanosoma brucei trypanothione reductase. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Read now
Jitendra Kuldeep, Karthik R.Pavneet Kaur, Neena Goyal & Mohammad Imran Siddiqi. (2021) Identification of potential anti-leishmanial agents using computational investigation and biological evaluation against trypanothione reductase. Journal of Biomolecular Structure and Dynamics 39:3, pages 960-969.
Read now
Read now
Articles from other publishers (48)
Naiara Dutra Barroso Gomes, Emanuel Paula Magalhães, Lyanna Rodrigues Ribeiro, John Washington Cavalcante, Marcelo Morais Gomes Maia, Felipe Ramon Cunha da Silva, Arif Ali, Márcia Machado Marinho, Emmanuel Silva Marinho, Hélcio Silva dos Santos, Alice Maria Costa Martins & Ramon Róseo Paula Pessoa Bezerra de Menezes. (2023) Trypanocidal potential of synthetic p-aminochalcones: In silico and in vitro evaluation. Bioorganic Chemistry 141, pages 106931.
Crossref
Crossref
Arun Dhurey, Subhro Mandal & Animesh Pramanik. (2023)
Efficient Synthesis of Fully Substituted and Diversely Functionalized Pyrazoles through
p
‐TSA Catalyzed One‐Pot Condensation of Cyclic
β
‐Diketones, Arylglyoxals and Arylhydrazones
. European Journal of Organic Chemistry 26:40.
Crossref
Crossref
M. Abirami, Banoth Karan Kumar, Faheem, Sanchita Dey, Samridhi Johri, Rosa M. Reguera, Rafael Balaña-Fouce, Kondapalli Venkata Gowri Chandra Sekhar & Murugesan Sankaranarayanan. (2023) Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds. European Journal of Medicinal Chemistry 257, pages 115471.
Crossref
Crossref
Meriem Lamrani, Talia Serseg, Khedidja Benarous, Ibrahim Sifi & Mohamed Yousfi. (2023) Hydroxycoumarins and some Flavonoids from Pistacia atlantica Desf. as
Multi-targets Inhibitors for Alzheimer’s Disease: Molecular Docking and
ADMET Studies. Current Computer-Aided Drug Design 19:3, pages 176-191.
Crossref
Crossref
Tanvi Goel, Deepali Bansode, Raihan Arikkattel Abdu & Sanal Dev. (2023) Molecular Docking, Microwave-Assisted Synthesis, Characterization and
Pharmacological Evaluation of 2,4,5-trisubstituted Imidazole’s. Current Microwave Chemistry 10:1, pages 43-52.
Crossref
Crossref
Natália Ferreira de Sousa, Helivaldo Diógenes da Silva Souza, Renata Priscila Barros de Menezes, Francinara da Silva Alves, Chonny Alexander Herrera Acevedo, Thaís Amanda de Lima Nunes, Zoe L. Sessions, Luciana Scotti, Eugene N. Muratov, Francisco Jaime Bezerra Mendonça-Junior, Klinger Antônio da Franca Rodrigues, Petrônio Filgueiras de Athayde Filho & Marcus Tullius Scotti. (2023) Selene-Ethylenelacticamides and N-Aryl-Propanamides as Broad-Spectrum Leishmanicidal Agents. Pathogens 12:1, pages 136.
Crossref
Crossref
Marilú Roxana Soto-Vásquez, Paul Alan Arkin Alvarado-García, Edison H. Osorio, Luciana R. Tallini & Jaume Bastida. (2023) Antileishmanial Activity of Clinanthus milagroanthus S. Leiva & Meerow (Amaryllidaceae) Collected in Peru. Plants 12:2, pages 322.
Crossref
Crossref
Valentina Noemi Madia, Davide Ialongo, Elisa Patacchini, Cécile Exertier, Lorenzo Antonelli, Gianni Colotti, Antonella Messore, Valeria Tudino, Francesco Saccoliti, Luigi Scipione, Andrea Ilari, Roberta Costi & Roberto Di Santo. (2023) Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site. Molecules 28:1, pages 338.
Crossref
Crossref
Andreina Henriquez-Figuereo, Cristina Morán-Serradilla, Eduardo Angulo-Elizari, Carmen Sanmartín & Daniel Plano. (2023) Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases. European Journal of Medicinal Chemistry 246, pages 115002.
Crossref
Crossref
Theo Battista, Stefano Federico, Simone Brogi, Luca Pozzetti, Tuhina Khan, Stefania Butini, Anna Ramunno, Eleonora Fiorentino, Stefania Orsini, Trentina Di Muccio, Annarita Fiorillo, Cécile Exertier, Daniel Di Risola, Gianni Colotti, Sandra Gemma, Andrea Ilari & Giuseppe Campiani. (2022) Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach. ACS Infectious Diseases 8:8, pages 1687-1699.
Crossref
Crossref
Surbhi Jain, Utkarsha Sahu, Awanish Kumar & Prashant Khare. (2022) Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates. Pharmaceutics 14:8, pages 1590.
Crossref
Crossref
Shweta Bisht, Lalan Kumar, Grace Kaul, Abdul Akhir, Deepanshi Saxena, Sidharth Chopra, R. Karthik, Neena Goyal & Sanjay Batra. (2022) Synthesis and Biological Evaluation of Substituted 3‐Isoxazolethioethers as Antileishmanial and Antibacterial Agents. ChemistrySelect 7:25.
Crossref
Crossref
Sujogya Kumar Panda, Zilda Cristiani Gazim, Shasank S. Swain, Marisa Cassia Vieira de Araujo Bento, Jéssica da Silva Sena, Marie Jeanne Mukazayire, Luc Van Puyvelde & Walter Luyten. (2022) Ethnomedicinal, Phytochemical and Pharmacological Investigations of Tetradenia riparia (Hochst.) Codd (Lamiaceae). Frontiers in Pharmacology 13.
Crossref
Crossref
Rajan Kumar Pandey, Rupal Ojha, Moodu Devender, Prince Sebastian, Madhulika Namdeo, Bajarang Vasant Kumbhar, Shyam Sundar, Radheshyam Maurya & Vijay Kumar Prajapati. (2022) Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection. Experimental Parasitology 236-237, pages 108250.
Crossref
Crossref
Huseyin Istanbullu & Gulsah Bayraktar. 2022. Leishmaniasis - General Aspects of a Stigmatized Disease. Leishmaniasis - General Aspects of a Stigmatized Disease.
Shilpa Chakrabarti & Neera Yadav. 2022. X‐Ray Fluorescence in Biological Sciences. X‐Ray Fluorescence in Biological Sciences
563
567
.
Anurag Kumar, Prajakta Nimsarkar & Shailza Singh. (2022) Probing the Interactions Responsible for the Structural Stability of Trypanothione Reductase Through Computer Simulation and Biophysical Characterization. The Protein Journal 41:2, pages 230-244.
Crossref
Crossref
Nibedita Pyne & Santanu Paul. (2021) Screening of medicinal plants unraveled the leishmanicidal credibility of Garcinia cowa; highlighting Norcowanin, a novel anti-leishmanial phytochemical through in-silico study. Journal of Parasitic Diseases 46:1, pages 202-214.
Crossref
Crossref
Fernanda S. Almeida, Gleyton L.S. Sousa, Juliana C. Rocha, Frederico F. Ribeiro, Márcia Rosa de Oliveira, Teresa Cristina Soares de Lima Grisi, Demetrius A.M. Araújo, Michelangela S. de C. Nobre, Rosane N. Castro, Ian P.G. Amaral, Tatjana S.L. Keesen & Ricardo Olímpio de Moura. (2021) In vitro anti-Leishmania activity and molecular docking of spiro-acridine compounds as potential multitarget agents against Leishmania infantum. Bioorganic & Medicinal Chemistry Letters 49, pages 128289.
Crossref
Crossref
Olivia Teixeira, Pedro Lacerda, Thamires Quadros Froes, Maria Cristina Nonato & Marcelo Santos Castilho. (2021) Druggable hot spots in trypanothione reductase: novel insights and opportunities for drug discovery revealed by DRUGpy. Journal of Computer-Aided Molecular Design 35:8, pages 871-882.
Crossref
Crossref
Sarra Maamri, Khedidja Benarous & Mohamed Yousfi. (2021) Identification of 3-Methoxycarpachromene and Masticadienonic Acid as New Target Inhibitors against Trypanothione Reductase from Leishmania Infantum Using Molecular Docking and ADMET Prediction. Molecules 26:11, pages 3335.
Crossref
Crossref
Minelly A. da Silva, Harold H. Fokoue, Saara N. Fialho, Ana Paula de A. dos Santos, Norton R. D. L. P. Rossi, Aurileya de J. Gouveia, Amália S. Ferreira, Guilherme M. Passarini, Ana F. G. Garay, Jorge J. Alfonso, Andreimar M. Soares, Fernando B. Zanchi, Massuo J. Kato, Carolina B. G. Teles & Christian C. Kuehn. (2021) Antileishmanial activity evaluation of a natural amide and its synthetic analogs against Leishmania (V.) braziliensis: an integrated approach in vitro and in silico. Parasitology Research 120:6, pages 2199-2218.
Crossref
Crossref
María Dolores Piñeyro, Diego Arias, Adriana Parodi-Talice, Sergio Guerrero & Carlos Robello. (2021) Trypanothione Metabolism as Drug Target for Trypanosomatids. Current Pharmaceutical Design 27:15, pages 1834-1846.
Crossref
Crossref
Valentina Noemi Madia, Alice Nicolai, Antonella Messore, Alessandro De Leo, Davide Ialongo, Valeria Tudino, Francesco Saccoliti, Daniela De Vita, Luigi Scipione, Marco Artico, Samanta Taurone, Ludovica Taglieri, Roberto Di Santo, Susanna Scarpa & Roberta Costi. (2021) Design, Synthesis and Biological Evaluation of New Pyrimidine Derivatives as Anticancer Agents. Molecules 26:3, pages 771.
Crossref
Crossref
Neena Goyal, Manveer Patel & Sanjay Batra. 2021. Drug Discovery and Drug Development. Drug Discovery and Drug Development
123
158
.
Igor A. Rodrigues, Andreza R. Garcia, Mariana M. Paz, Rogério G. D. Grilo Junior, Ana Claudia F. Amaral & Anderson S. Pinheiro. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
143
180
.
Francesco Saccoliti, Roberto Di Santo & Roberta Costi. (2020) Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism. ChemMedChem 15:24, pages 2420-2435.
Crossref
Crossref
Shweta Raj, Santanu Sasidharan, S. N. Balaji & Prakash Saudagar. (2020) An overview of biochemically characterized drug targets in metabolic pathways of Leishmania parasite. Parasitology Research 119:7, pages 2025-2037.
Crossref
Crossref
Justice Afrifa Crentsil, Lauve Rachel Tchokouaha Yamthe, Barbara Zenabu Anibea, Emmanuel Broni, Samuel Kojo Kwofie, John Kweku Amissah Tetteh & Dorcas Osei-Safo. (2020) Leishmanicidal Potential of Hardwickiic Acid Isolated From Croton sylvaticus. Frontiers in Pharmacology 11.
Crossref
Crossref
Theo Battista, Gianni Colotti, Andrea Ilari & Annarita Fiorillo. (2020) Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases. Molecules 25:8, pages 1924.
Crossref
Crossref
Samuel K. Kwofie, Emmanuel Broni, Bismark Dankwa, Kweku S. Enninful, Gabriel B. Kwarko, Louis Darko, Ravi Durvasula, Prakasha Kempaiah, Brijesh Rathi, Whelton A. Miller III, Abu Yaya & Michael D. Wilson. (2020) Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic Potential. Current Topics in Medicinal Chemistry 20:5, pages 349-366.
Crossref
Crossref
Ludovica Taglieri, Francesco Saccoliti, Alice Nicolai, Giovanna Peruzzi, Valentina Noemi Madia, Valeria Tudino, Antonella Messore, Roberto Di Santo, Marco Artico, Samanta Taurone, Maurizio Salvati, Roberta Costi & Susanna Scarpa. (2019) Discovery of a pyrimidine compound endowed with antitumor activity. Investigational New Drugs 38:1, pages 39-49.
Crossref
Crossref
Enzo Agostinelli. (2020) Biochemical and pathophysiological properties of polyamines. Amino Acids 52:2, pages 111-117.
Crossref
Crossref
Gianni Colotti, Francesco Saccoliti, Marina Gramiccia, Trentina Di Muccio, Jay Prakash, Sunita Yadav, Vikash Kumar Dubey, Giulio Vistoli, Theo Battista, Stefano Mocci, Annarita Fiorillo, Aasia Bibi, Valentina Noemi Madia, Antonella Messore, Roberta Costi, Roberto Di Santo & Andrea Ilari. (2019) Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism. Amino Acids 52:2, pages 247-259.
Crossref
Crossref
Lee, Kim, Hayat & Shin. (2019) Recent Advances in the Discovery of Novel Antiprotozoal Agents. Molecules 24:21, pages 3886.
Crossref
Crossref
Félix Matadamas-Martínez, Alicia Hernández-Campos, Alfredo Téllez-Valencia, Alejandra Vázquez-Raygoza, Sandra Comparán-Alarcón, Lilián Yépez-Mulia & Rafael Castillo. (2019) Leishmania mexicana Trypanothione Reductase Inhibitors: Computational and Biological Studies. Molecules 24:18, pages 3216.
Crossref
Crossref
Raoul De Gasparo, Ondrej Halgas, Dora Harangozo, Marcel Kaiser, Emil F. Pai, R. Luise Krauth‐Siegel & François Diederich. (2019)
Targeting a Large Active Site: Structure‐Based Design of Nanomolar Inhibitors of
Trypanosoma brucei
Trypanothione Reductase
. Chemistry – A European Journal 25:49, pages 11416-11421.
Crossref
Crossref
Syed Majid Shah, Farhat Ullah, Muhammad Ayaz, Abdul Sadiq, Sajid Hussain, Azhar-ul-Haq Ali Shah, Syed Adnan Ali Shah, Abdul wadood & Akhtar Nadhman. (2019) β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. as potential anti-leishmanial agent against leishmania tropica: Docking and molecular insights. Steroids 148, pages 56-62.
Crossref
Crossref
Marta Díaz, Héctor de Lucio, Esther Moreno, Socorro Espuelas, Carlos Aydillo, Antonio Jiménez-Ruiz, Miguel Ángel Toro, Killian Jesús Gutiérrez, Victor Martínez-Merino, Alfonso Cornejo, Juan Antonio Palop, Carmen Sanmartín & Daniel Plano. (2019) Synthesis and Leishmanicidal Activity of Novel Urea, Thiourea, and Selenourea Derivatives of Diselenides. Antimicrobial Agents and Chemotherapy 63:5.
Crossref
Crossref
Francesco Saccoliti, Valentina Noemi Madia, Valeria Tudino, Alessandro De Leo, Luca Pescatori, Antonella Messore, Daniela De Vita, Luigi Scipione, Reto Brun, Marcel Kaiser, Pascal Mäser, Claudia M. Calvet, Gareth K. Jennings, Larissa M. Podust, Giacomo Pepe, Roberto Cirilli, Cristina Faggi, Annalise Di Marco, Maria Rosaria Battista, Vincenzo Summa, Roberta Costi & Roberto Di Santo. (2019)
Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1
H
-pyrrolyl)(phenyl)methyl-1
H
-imidazole Derivatives as Antiprotozoal Agents
. Journal of Medicinal Chemistry 62:3, pages 1330-1347.
Crossref
Crossref
Anurag Kumar, Nutan Chauhan & Shailza Singh. (2019) Understanding the Cross-Talk of Redox Metabolism and Fe-S Cluster Biogenesis in Leishmania Through Systems Biology Approach. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Crossref
Lorenzo Turcano, Esther Torrente, Antonino Missineo, Matteo Andreini, Marina Gramiccia, Trentina Di Muccio, Ilaria Genovese, Annarita Fiorillo, Steven Harper, Alberto Bresciani, Gianni Colotti & Andrea Ilari. (2018) Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLOS Neglected Tropical Diseases 12:11, pages e0006969.
Crossref
Crossref
Andrea Ilari, Ilaria Genovese, Fabiana Fiorillo, Theo Battista, Ilenia De Ionna, Annarita Fiorillo & Gianni Colotti. (2018) Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors. Molecular Pharmaceutics 15:8, pages 3069-3078.
Crossref
Crossref
Francesco Saccoliti, Valentina Noemi Madia, Valeria Tudino, Alessandro De Leo, Luca Pescatori, Antonella Messore, Daniela De Vita, Luigi Scipione, Reto Brun, Marcel Kaiser, Pascal Mäser, Claudia Magalhaes Calvet, Gareth K. Jennings, Larissa M. Podust, Roberta Costi & Roberto Di Santo. (2018) Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents. European Journal of Medicinal Chemistry 156, pages 53-60.
Crossref
Crossref
Raoul De Gasparo, Elke Brodbeck‐Persch, Steve Bryson, Nina B. Hentzen, Marcel Kaiser, Emil F. Pai, R. Luise Krauth‐Siegel & François Diederich. (2018) Biological Evaluation and X‐ray Co‐crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma. ChemMedChem 13:9, pages 957-967.
Crossref
Crossref
Margherita Ortalli, Andrea Ilari, Gianni Colotti, Ilenia De Ionna, Theo Battista, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Rita M.C. Di Martino, Giovanna A. Gentilomi, Stefania Varani & Federica Belluti. (2018) Identification of chalcone-based antileishmanial agents targeting trypanothione reductase. European Journal of Medicinal Chemistry 152, pages 527-541.
Crossref
Crossref
Saravanan Vijayakumar & Pradeep Das. (2018) Recent progress in drug targets and inhibitors towards combating leishmaniasis. Acta Tropica 181, pages 95-104.
Crossref
Crossref
Chiara Borsari, Antonio Quotadamo, Stefania Ferrari, Alberto Venturelli, Anabela Cordeiro-da-Silva, Nuno Santarem & Maria Paola Costi. 2018. Neglected Diseases: Extensive Space for Modern Drug Discovery. Neglected Diseases: Extensive Space for Modern Drug Discovery
39
95
.